biotech analyst roundup 🧬 Biotech Analyst Roundup: IOVA and AGIO Lead the Bullish Pack as Moderna Reignites mRNA Oncology StockInsight™ Biotech Research | August 21, 2026 🔎 Focus: Analyst sentiment • Clinical catalysts • FDA events • Commercial growth • Valuation • Risk 🧬 Biotech Market Pulse The biotech sector is entering a highly event-driven period, with investors balancing clinical…

This content is for subscribers only. Please click here to see our plans.

biotech & health insights 🧬 Biotech News — August 28, 2026 Celularity Surges 139% as New Jersey Manufacturing Deal Targets $300 Million in Purchase Orders Biotechnology stocks delivered another highly active session as investors responded to manufacturing partnerships, clinical-trial data, oncology developments, financing transactions and Nasdaq compliance measures. Celularity was the standout mover, soaring 139% after establishing a domestic manufacturing…